A strategic partnership between Lionheart Health and ElectroMedical Technologies is poised to transform wound care treatment through advanced bioelectric healing technologies. The joint venture combines Lionheart's patented bioelectric signaling software with ElectroMed's sophisticated device platform, targeting critical patient needs such as preventing limb amputations.
The collaboration emerges from promising pilot study results demonstrating extraordinary potential in wound healing interventions. Previous standalone studies conducted in multiple countries revealed that over 90% of patients with non-healing wounds—previously considered candidates for amputation—successfully retained their limbs after treatment.
The planned clinical study will explore multiple treatment approaches, including bioelectric stimulation alone, combined with enhanced protein regeneration techniques, and potential integration with stem cell and membrane graft technologies. This comprehensive research strategy aims to significantly accelerate wound healing and improve long-term patient outcomes.
With approximately 185,000 amputations occurring annually in the United States, predominantly related to non-healing wounds, the joint venture has set an ambitious goal of reducing this number by more than 50% within the next decade. The partnership leverages Lionheart's extensive patent portfolio of over 500 claims related to bioelectric protein expressions and tissue regeneration, complemented by ElectroMed's 18 years of experience in electrical stimulation device development.
Matthew Wolfson, CEO of ElectroMed Technologies, emphasized the transformative potential of their technology, suggesting it could revolutionize wound care for the next century. The approach is particularly promising for diabetic ulcer treatment, a condition that frequently leads to complex wound healing challenges.
The joint venture plans to expand accessibility through a licensing model, with intentions to establish 124 certified clinics worldwide trained in their patented bioelectric treatment protocols. This strategy will enable broader implementation of their innovative wound healing approach while generating revenue through patient service royalties.
By combining advanced technological capabilities and a focused research approach, Lionheart Health and ElectroMedical Technologies are positioning themselves at the forefront of regenerative medicine, offering hope to patients facing potentially life-altering wound healing complications.
